<DOC>
	<DOCNO>NCT00055666</DOCNO>
	<brief_summary>RATIONALE : Beclomethasone may effective treat patient graft-versus-host disease gastrointestinal tract . PURPOSE : Compassionate use beclomethasone treat patient graft-versus-host disease gastrointestinal tract respond previous therapy .</brief_summary>
	<brief_title>Compassionate Use Beclomethasone Treating Patients With Graft-Versus-Host Disease Gastrointestinal Tract</brief_title>
	<detailed_description>OBJECTIVES : - Provide beclomethasone dipropionate patient gastrointestinal graft-versus-host disease refractory standard therapy contraindication systemic steroid . - Minimize serious side effect associate systemic steroid use patient . OUTLINE : Patients receive oral beclomethasone dipropionate 4 time daily 28 day absence graft-versus-host disease progression unacceptable toxicity . Patients may receive second course 31 day symptoms graft-versus-host disease persist . Patients may receive 4 treatment ( 1 2 course ) per year . PROJECTED ACCRUAL : A total 24-45 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinically pathologically confirm graftversushost disease gastrointestinal tract Failed standard therapy contraindication systemic immunosuppressive agent No clinically significant intestinal infection ( confirmed stool culture ) No persistent vomit oral intake Not candidate approve beclomethasone dipropionate Enteron Pharmaceuticals protocol PATIENT CHARACTERISTICS : Age 4 70 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Able swallow medication PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy See Disease Characteristics Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>graft versus host disease</keyword>
</DOC>